APTO logo

Aptose Biosciences (APTO) Shareholders Equity

Annual Shareholders Equity

-$2.90 M
-$40.64 M-107.69%

31 December 2023

APTO Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$9.13 M
-$6.96 M-319.76%

30 September 2024

APTO Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APTO Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-107.7%-217.5%
3 y3 years-102.4%-110.3%
5 y5 years-120.6%-133.3%

APTO Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-102.4%at low-110.3%at low
5 y5 years-102.4%at low-107.1%at low
alltimeall time-102.4%+62.1%-107.1%at low

Aptose Biosciences Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
-$9.13 M(+319.8%)
June 2024
-
-$2.18 M(-1688.3%)
Mar 2024
-
$137.00 K(-104.7%)
Dec 2023
-$2.90 M(-107.7%)
-$2.90 M(-137.3%)
Sept 2023
-
$7.78 M(-43.6%)
June 2023
-
$13.79 M(-47.0%)
Mar 2023
-
$25.99 M(-31.1%)
Dec 2022
$37.74 M(-49.2%)
$37.74 M(-19.4%)
Sept 2022
-
$46.81 M(-15.6%)
June 2022
-
$55.49 M(-15.0%)
Mar 2022
-
$65.28 M(-12.1%)
Dec 2021
$74.24 M(-37.6%)
$74.24 M(-16.3%)
Sept 2021
-
$88.68 M(-9.7%)
June 2021
-
$98.19 M(-10.3%)
Mar 2021
-
$109.41 M(-8.0%)
Dec 2020
$118.92 M(+26.6%)
$118.92 M(-7.9%)
Sept 2020
-
$129.16 M(+63.0%)
June 2020
-
$79.22 M(-9.2%)
Mar 2020
-
$87.24 M(-7.1%)
Dec 2019
$93.93 M(+567.0%)
$93.93 M(+242.4%)
Sept 2019
-
$27.43 M(-18.7%)
June 2019
-
$33.76 M(+118.9%)
Mar 2019
-
$15.42 M(+9.5%)
Dec 2018
$14.08 M(+38.0%)
$14.08 M(+1.1%)
Sept 2018
-
$13.93 M(-17.5%)
June 2018
-
$16.89 M(+16.7%)
Mar 2018
-
$14.47 M(+41.8%)
Dec 2017
$10.20 M(+39.2%)
$10.20 M(+3.3%)
Sept 2017
-
$9.88 M(-4.0%)
June 2017
-
$10.29 M(+32.7%)
Mar 2017
-
$7.75 M(+5.8%)
Dec 2016
$7.33 M(-46.3%)
$7.33 M(+6.2%)
Sept 2016
-
$6.90 M(-23.9%)
June 2016
-
$9.07 M(-18.0%)
Mar 2016
-
$11.06 M(-19.0%)
Dec 2015
$13.65 M(-45.9%)
$13.65 M(-19.0%)
Sept 2015
-
$16.86 M(-16.0%)
June 2015
-
$20.07 M(-7.0%)
Mar 2015
-
$21.59 M(-24.6%)
Dec 2014
$25.22 M(-3.8%)
-
Sept 2014
-
$28.61 M(+9.2%)
May 2014
$26.21 M(-3558.6%)
$26.21 M(+620.6%)
Feb 2014
-
$3.64 M(-343.8%)
Nov 2013
-
-$1.49 M(-8.5%)
Aug 2013
-
-$1.63 M(+115.2%)
May 2013
-$757.80 K(-61.5%)
-$757.80 K(-293.5%)
Feb 2013
-
$391.70 K(-76.2%)
Nov 2012
-
$1.64 M(-47.5%)
Aug 2012
-
$3.13 M(-259.0%)
May 2012
-$1.97 M(-904.3%)
-$1.97 M(+82.7%)
Feb 2012
-
-$1.08 M(+1534.6%)
Nov 2011
-
-$65.90 K(-106.0%)
Aug 2011
-
$1.09 M(+345.4%)
May 2011
$244.70 K
$244.70 K(-86.1%)
Feb 2011
-
$1.76 M(+30.5%)
DateAnnualQuarterly
Nov 2010
-
$1.35 M(-186.3%)
Aug 2010
-
-$1.56 M(+204.4%)
May 2010
-$513.70 K(-93.3%)
-$513.70 K(-146.5%)
Feb 2010
-
$1.10 M(-51.5%)
Nov 2009
-
$2.28 M(+63.2%)
Aug 2009
-
$1.40 M(-118.2%)
May 2009
-$7.66 M(+97.8%)
-$7.66 M(+45.5%)
Feb 2009
-
-$5.27 M(+45.7%)
Nov 2008
-
-$3.61 M(+50.6%)
Aug 2008
-
-$2.40 M(-38.1%)
May 2008
-$3.87 M(-644.7%)
-$3.87 M(+510.1%)
Feb 2008
-
-$635.00 K(-123.1%)
Nov 2007
-
$2.75 M(-43.0%)
Aug 2007
-
$4.83 M(+578.6%)
May 2007
$711.20 K(-130.6%)
$711.20 K(-63.9%)
Feb 2007
-
$1.97 M(-43.9%)
Nov 2006
-
$3.51 M(-42.2%)
Aug 2006
-
$6.07 M(-361.4%)
May 2006
-$2.32 M(-122.0%)
-$2.32 M(-4327.9%)
Feb 2006
-
$54.90 K(-98.2%)
Nov 2005
-
$3.03 M(-55.1%)
Aug 2005
-
$6.75 M(-36.2%)
May 2005
$10.57 M(-49.6%)
$10.57 M(-17.1%)
Feb 2005
-
$12.76 M(-20.0%)
Nov 2004
-
$15.95 M(-7.2%)
Aug 2004
-
$17.19 M(-18.1%)
May 2004
$20.99 M(-0.3%)
$20.99 M(-23.3%)
Feb 2004
-
$27.38 M(-20.4%)
Nov 2003
-
$34.37 M(-6.0%)
Aug 2003
-
$36.55 M(+73.6%)
May 2003
$21.05 M(-27.1%)
$21.05 M(-4.2%)
Feb 2003
-
$21.97 M(-5.1%)
Nov 2002
-
$23.15 M(-10.1%)
Aug 2002
-
$25.74 M(-10.9%)
May 2002
$28.89 M(-20.6%)
$28.89 M(-3.2%)
Feb 2002
-
$29.85 M(-6.3%)
Nov 2001
-
$31.84 M(-6.9%)
Aug 2001
-
$34.20 M(-6.0%)
May 2001
$36.38 M(-20.7%)
$36.38 M(-8.9%)
Feb 2001
-
$39.95 M(-2.6%)
Nov 2000
-
$41.02 M(-9.1%)
Aug 2000
-
$45.13 M(-1.7%)
May 2000
$45.89 M(+3461.0%)
$45.89 M(+131.2%)
Feb 2000
-
$19.85 M(+26.0%)
Nov 1999
-
$15.76 M(+1862.3%)
Aug 1999
-
$802.90 K(-37.7%)
May 1999
$1.29 M(-60.9%)
$1.29 M(-39.3%)
Feb 1999
-
$2.12 M(+12.4%)
Nov 1998
-
$1.89 M(-21.5%)
Aug 1998
-
$2.40 M(-27.0%)
May 1998
$3.30 M(-52.2%)
$3.30 M(-13.2%)
Feb 1998
-
$3.79 M(-21.7%)
Nov 1997
-
$4.85 M(-20.8%)
Aug 1997
-
$6.12 M
May 1997
$6.89 M
-

FAQ

  • What is Aptose Biosciences annual stockholders equity?
  • What is the all time high annual shareholders equity for Aptose Biosciences?
  • What is Aptose Biosciences annual shareholders equity year-on-year change?
  • What is Aptose Biosciences quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Aptose Biosciences?
  • What is Aptose Biosciences quarterly shareholders equity year-on-year change?

What is Aptose Biosciences annual stockholders equity?

The current annual shareholders equity of APTO is -$2.90 M

What is the all time high annual shareholders equity for Aptose Biosciences?

Aptose Biosciences all-time high annual stockholders equity is $118.92 M

What is Aptose Biosciences annual shareholders equity year-on-year change?

Over the past year, APTO annual stockholders equity has changed by -$40.64 M (-107.69%)

What is Aptose Biosciences quarterly stockholders equity?

The current quarterly shareholders equity of APTO is -$9.13 M

What is the all time high quarterly shareholders equity for Aptose Biosciences?

Aptose Biosciences all-time high quarterly stockholders equity is $129.16 M

What is Aptose Biosciences quarterly shareholders equity year-on-year change?

Over the past year, APTO quarterly stockholders equity has changed by -$16.91 M (-217.46%)